How cellular RNA machinery shapes facial bone and cartilage development

Understanding RNA Polymerase III transcription in neural crest cell and craniofacial development

NIH-funded research University of Colorado Denver · NIH-11308355

This project looks at how a cell's RNA-making machinery affects early facial development to better understand craniofacial birth defects like Treacher Collins syndrome.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-11308355 on NIH RePORTER

What this research studies

Researchers are studying the cells that form most of the face (neural crest cells) to see how problems in RNA production lead to craniofacial birth defects. They will use laboratory models, including zebrafish, and molecular techniques to examine the roles of RNA Polymerase I and III and specific genes linked to Treacher Collins syndrome. Prior work found that disrupting some RNA polymerase components causes cell death in neural crest progenitors, and this project will look specifically at Pol III and its products like tRNAs. The goal is to reveal why these disruptions affect facial tissues and to point toward ways to prevent or treat these birth defects in the future.

Who could benefit from this research

Good fit: Although this is lab-based work rather than a clinical trial, the findings are most relevant to people and families affected by Treacher Collins syndrome and other congenital craniofacial anomalies.

Not a fit: People with unrelated medical conditions or those seeking immediate clinical treatments are unlikely to directly benefit from this basic science project.

Why it matters

Potential benefit: If successful, the research could identify biological causes and potential targets that help prevent or guide treatments for craniofacial birth defects such as Treacher Collins syndrome.

How similar studies have performed: Previous studies in zebrafish showed that disrupting Pol I-related genes reduces ribosomal RNA and causes neural crest cell death linked to craniofacial defects, but the role of Pol III in these processes is largely untested.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Berry syndromeBerry-Treacher Collins syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.